The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 10, 2016

Filed:

Jun. 09, 2014
Applicants:

Otonomy, Inc., San Diego, CA (US);

The Regents of the University of California, Oakland, CA (US);

Inventors:

Jay Lichter, Rancho Santa Fe, CA (US);

Andrew M. Trammel, Olathe, KS (US);

Fabrice Piu, San Diego, CA (US);

Qiang Ye, San Diego, CA (US);

Michael Christopher Scaife, Los Altos, CA (US);

Benedikt Vollrath, San Diego, CA (US);

Sergio G. Duron, San Diego, CA (US);

Luis A. Dellamary, San Marcos, CA (US);

Carl Lebel, Malibu, CA (US);

Jeffrey P. Harris, La Jolla, CA (US);

Assignees:

OTONOMY, INC., San Diego, CA (US);

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, Oakland, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 9/02 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/00 (2006.01); A61K 31/167 (2006.01); A61K 31/195 (2006.01); A61K 31/5513 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2006.01); A61K 47/14 (2006.01); A61K 47/38 (2006.01); A61K 47/44 (2006.01); A61K 31/197 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0046 (2013.01); A61K 9/06 (2013.01); A61K 31/00 (2013.01); A61K 31/167 (2013.01); A61K 31/195 (2013.01); A61K 31/197 (2013.01); A61K 31/5513 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/38 (2013.01); A61K 47/44 (2013.01);
Abstract

Disclosed herein are compositions and methods for the treatment of otic disorders with CNS modulating agent compositions and compositions administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and compositions onto or via perfusion into the targeted auris structure(s).


Find Patent Forward Citations

Loading…